Patent Oppositions in protein and peptide compounds industry

Explore the competitive field of protein and peptide compounds where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in protein and peptide compounds technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the protein and peptide compounds industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the protein and peptide compounds industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 23, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Compositions And Methods For Growth Factor ModulationSCHOLAR ROCKJun 16, 2026STRAWMAN
PolypeptidesVHSQUAREDJun 10, 2026SANOFI
Antibody Producing Non-Human MammalsMERUSJun 3, 2026KYMAB
Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKUMay 27, 2026POHLMAN
Neutralization Of Inhibitory Pathways In LymphocytesINNATE PHARMAMay 13, 2026STRAWMAN
Powdery Mildew Resistance Genes In CarrotBEJO ZADENMay 12, 2026NUNHEMS NETHERLANDS
The Use Of Fatty Alcohol Polyglycol Ether To Reduce Endotoxin Activity And/Or Endotoxins In Collagen-Containing And/Or Collagen-Derived ProductsROUSSELOTMay 12, 2026VO
Methods For Treating Nasal Polyposis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSMay 6, 2026ENGELHARD
Functionalized Peptides As Antiviral AgentsENANTA PHARMACEUTICALSMay 6, 2026PFIZER
Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe ExcoriationGALDERMA HOLDINGApr 30, 2026CABINET BECKER ET ASSOCIES

To stay ahead in the competitive protein and peptide compounds industry, companies are constantly innovating. Here are the top patents facing oppositions in the protein and peptide compounds industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 23, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH16
Jan 10, 2018Method To Improve Virus Removal In Protein PurificationGENENTECH15
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS15
Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH14
Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH12
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA12
May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHE12
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDIS BIOTECH11
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB11
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI11